A recent article published in the Children’s Hospital of Philadelphia’s (CHOP’s) Research in Action blog by Dr. Daniel Corwin emphasizes the importance of using CHOP’s visio-vestibular examination (VVE) as a part of first-line concussion management in the emergency department.

Having first achieved FDA approval in 2019, Oculogica’s EyeBOX remains the “only FDA-cleared and Health Canada registered diagnostic aid for concussion that does not require a pre-injury baseline test.” The new FDA label allows providers to use the EyeBOX to monitor a patient’s recovery over time by comparing the patient’s recovery to normative data.

Vision therapy may be valuable for those suffering vision problems after a mild traumatic brain injury (mTBI). Optometrist Maureen Oyaide-Ofenor explains the process of vision therapy in an article published in Optometry Times Journal.

Results from a recent study published in the Clinical Journal of Sports Medicine indicated that youth with exercise-induced vision dysfunction following sport-related concussion were at “a 3-folder greater risk” of developing persistent post-concussive symptoms (PPCS) compared to those without exercise-induced vision dysfunction.

A study found that over half of participants had persistent sensorimotor impairments at four weeks to six months after suffering a mild traumatic brain injury (mTBI). The authors note that “These disturbances were evident regardless of whether ongoing symptoms were reported,” including those patients who said they were asymptomatic.

A day-long course, “Evidence-based Management of Vision Deficits Following Mild to Moderate TBI” will be presented by one of the leading researchers and clinicians in the field, Neera Kapoor, OD, MS, FAAO, FCOVD-A.